APA

Calvo E., Azaro A., Rodon J., Dirix L., Huizing M., Senecal F. M., LoRusso P., Yee L., Poggesi I., de Jong J., Triantos S., Park Y. C., Knoblauch R. E., Parekh T. V., Demetri G. D. & von Mehren M. (20190225). Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trial. : Investigational new drugs.

Chicago

Calvo Emiliano, Azaro Analia, Rodon Jordi, Dirix Luc, Huizing Manon, Senecal Francis Mark, LoRusso Patricia, Yee Lorrin, Poggesi Italo, de Jong Jan, Triantos Spyros, Park Youn C, Knoblauch Roland E, Parekh Trilok V, Demetri George D and von Mehren Margaret. 20190225. Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trial. : Investigational new drugs.

Harvard

Calvo E., Azaro A., Rodon J., Dirix L., Huizing M., Senecal F. M., LoRusso P., Yee L., Poggesi I., de Jong J., Triantos S., Park Y. C., Knoblauch R. E., Parekh T. V., Demetri G. D. and von Mehren M. (20190225). Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trial. : Investigational new drugs.

MLA

Calvo Emiliano, Azaro Analia, Rodon Jordi, Dirix Luc, Huizing Manon, Senecal Francis Mark, LoRusso Patricia, Yee Lorrin, Poggesi Italo, de Jong Jan, Triantos Spyros, Park Youn C, Knoblauch Roland E, Parekh Trilok V, Demetri George D and von Mehren Margaret. Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trial. : Investigational new drugs. 20190225.